Exploring the role of polyphenols in rheumatoid arthritis
- PMID: 33998910
- DOI: 10.1080/10408398.2021.1924613
Exploring the role of polyphenols in rheumatoid arthritis
Abstract
Rheumatoid arthritis (RA) is a chronic, inflammatory and autoimmune disorder which is mainly characterized by inflammation in joints, bone erosions and cartilaginous destruction that leads to joint dysfunction, deformation, and/or permanent functional impairment. The prevalence of RA is increasing, incurring a considerable burden on healthcare systems globally. The exact etiology of RA is unknown, with various pathways implicated in its pathophysiology. Non-steroidal anti-inflammatory drugs (NSAIDs) including celecoxib, diclofenac and ibuprofen, disease-modifying anti-rheumatic drugs (DMARD) including azathioprine, methotrexate and cyclosporine, biological agents including anakinra, infliximab, and rituximab and immunosuppressants are used for symptomatic relief in patients with RA, but these medications have severe adverse effects such as gastric ulcers, hypertension, hepatotoxicity and renal abnormalities which restrict their use in the treatment of RA; new RA treatments with minimal side-effects are urgently required. There is accumulating evidence that dietary polyphenols may show therapeutic efficacy in RA through their antioxidant, anti-inflammatory, apoptotic, and immunosuppressant activities and modulation of the tumor necrosis factor-α (TNF-α), interleukin (IL)-6, mitogen-activated protein kinase (MAPK), IL-1β, c-Jun N-terminal kinase (JNK), and nuclear factor κ light-chain-enhancer of activated B cell (NF-κB) pathways. While resveratrol, genistein, carnosol, epigallocatechin gallate, curcumin, kaempferol, and hydroxytyrosol have also been studied for the treatment of RA, the majority of data are derived from animal models. Here, we review the various pathways involved in the development of RA and the preclinical and clinical data supporting polyphenols as potential therapeutic agents in RA patients. Our review highlights that high-quality clinical studies are required to decisively establish the anti-rheumatic efficacy of polyphenolic compounds.
Keywords: Polyphenol; anti-inflammatory; antioxidant; apoptosis; rheumatoid arthritis.
Similar articles
-
Role of polyphenolics in the management of rheumatoid arthritis through intracellular signaling pathways: a mechanistic review.Inflammopharmacology. 2025 May;33(5):2263-2275. doi: 10.1007/s10787-025-01731-z. Epub 2025 Apr 12. Inflammopharmacology. 2025. PMID: 40220198 Review.
-
Could Polyphenols Help in the Control of Rheumatoid Arthritis?Molecules. 2019 Apr 22;24(8):1589. doi: 10.3390/molecules24081589. Molecules. 2019. PMID: 31013659 Free PMC article. Review.
-
Polyphenolic extract from extra virgin olive oil inhibits the inflammatory response in IL-1β-activated synovial fibroblasts.Br J Nutr. 2019 Jan;121(1):55-62. doi: 10.1017/S0007114518002829. Epub 2018 Oct 26. Br J Nutr. 2019. PMID: 30360768
-
Theaflavin-3, 3'-Digallate Attenuates Rheumatoid Inflammation in Mice Through the Nuclear Factor-κB and MAPK Pathways.Arch Immunol Ther Exp (Warsz). 2019 Jun;67(3):153-160. doi: 10.1007/s00005-019-00536-7. Epub 2019 Mar 14. Arch Immunol Ther Exp (Warsz). 2019. PMID: 30874838
-
FM0807 decelerates experimental arthritis progression by inhibiting inflammatory responses and joint destruction via modulating NF-κB and MAPK pathways.Biosci Rep. 2019 Sep 3;39(9):BSR20182263. doi: 10.1042/BSR20182263. Print 2019 Sep 30. Biosci Rep. 2019. PMID: 31431516 Free PMC article.
Cited by
-
Kaempferol as a multi-targeted phytotherapeutic for arthritis: systematic review and meta-analysis of preclinical models.Inflammopharmacology. 2025 Jul;33(7):3519-3542. doi: 10.1007/s10787-025-01835-6. Epub 2025 Jul 5. Inflammopharmacology. 2025. PMID: 40617896 Review.
-
Research on the Mechanism of Kaempferol for Treating Senile Osteoporosis by Network Pharmacology and Molecular Docking.Evid Based Complement Alternat Med. 2022 Feb 3;2022:6741995. doi: 10.1155/2022/6741995. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35154351 Free PMC article.
-
Intestinal Microbiota Reduction Followed by Fasting Discloses Microbial Triggering of Inflammation in Rheumatoid Arthritis.J Clin Med. 2023 Jun 28;12(13):4359. doi: 10.3390/jcm12134359. J Clin Med. 2023. PMID: 37445394 Free PMC article.
-
Inhibitory Effects of IL-6-Mediated Matrix Metalloproteinase-3 and -13 by Achyranthes japonica Nakai Root in Osteoarthritis and Rheumatoid Arthritis Mice Models.Pharmaceuticals (Basel). 2021 Aug 7;14(8):776. doi: 10.3390/ph14080776. Pharmaceuticals (Basel). 2021. PMID: 34451873 Free PMC article.
-
Effects of Etanercept and Adalimumab on Serum Levels of Cartilage Remodeling Markers in Women with Rheumatoid Arthritis.J Clin Med. 2023 Aug 9;12(16):5185. doi: 10.3390/jcm12165185. J Clin Med. 2023. PMID: 37629227 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous